Ona Therapeutics to develop ADC with WuXi’s payload-linker platform
WuXi XDC Cayman is to provide Ona Therapeutics with an exclusive global licence to its WuXiTecan-2 platform to develop an ADC candidate.
Read the full article on the original site.
Read Full Article